Researchers Identify Gene Behind Key Inflammatory Pathway
Scientists have solved a 30-year mystery by pinpointing the gene responsible for the 5-oxoETE inflammatory signaling pathway.
Updated on Oct. 16, 2026 in Life Sciences
Live Poll
Do you trust that new research into cellular inflammatory pathways will yield effective future health treatments?
Researchers at Memorial Sloan Kettering Cancer Center have identified the human gene DHRS7 as the source of the enzyme that triggers the 5-oxoETE signaling pathway. This breakthrough settles a 30-year scientific puzzle regarding the mechanism of this inflammatory response.
Why it matters
The 5-oxoETE pathway serves as a protective mechanism for healthy cells against inflammation-related damage. Identifying its genetic roots may eventually lead to new therapeutic strategies for preserving tissue integrity.
Researchers screened candidate genes in human cells and utilized zebrafish models, which maintain an intact 5-oxoETE pathway, to overcome the limitation that mice lack the necessary receptors for 5-oxoETE binding.
The players
Memorial Sloan Kettering Cancer Center
This facility is a world-renowned cancer treatment and research institution based in New York that led the recent gene identification study.
McGill University
This is a public research university in Montreal, Canada, where the initial investigation into 5-oxoETE molecules began in 1992.
The details
By silencing individual candidate genes, scientists confirmed that DHRS7 is essential for the pathway, as its disruption eliminates enzyme activity and leaves intestinal cells vulnerable to bacterial stress. Mutations in this gene and its receptor, OXER1, have been observed in gastrointestinal and uterine tumors.
Timeline
In 1992, researchers at McGill University first began investigating 5-oxoETE molecules.
The research findings were published in the journal Nature on October 16, 2026.
The Big Picture
This discovery marks a foundational shift in our understanding of the 5-oxoETE inflammatory signaling pathway by finally revealing the genetic component that controls it. The study bridges a long-standing gap in lipid signaling research, moving the field past a 30-year investigative stall.
This finding opens a new avenue for medical research that could eventually lead to treatments designed to shield healthy cells from inflammatory damage. While currently in the experimental stage, these insights offer long-term potential for managing chronic inflammation.
The takeaway
Understanding the genetic drivers of inflammation provides scientists with a roadmap to minimize collateral tissue damage during illness or injury. Future therapeutic efforts may focus on harnessing these natural protective pathways to improve clinical outcomes.
What happens next
Future research will aim to determine the specific mechanisms by which physical injury activates the 5-oxoETE pathway and whether modulating this process can protect healthy tissues.
Further reading
For more background on current research developments, visit our Life Sciences section.
Source note: This article includes information reported by Drug Target Review.
Live Poll
Do you trust that new research into cellular inflammatory pathways will yield effective future health treatments?
